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Key points
 Retinoic acid (RA) and ghrelin levels are altered in human hypoplastic lungs when compared to
healthy lungs. Although considerable data have been obtained about RA, ghrelin and bombesin
in the congenital diaphragmatic hernia (CDH) rat model, neuroendocrine factors have never
been associated with the RA signalling pathway in this animal model.
 In this study, the interaction between neuroendocrine factors and RAwas explored in the CDH
rat model.
 The authors found that normal fetal lung explants treated with RA, bombesin and ghrelin
showed an increase in lung growth. Hypoplastic lungs presented higher expression levels of the
RA receptors α and γ. Moreover bombesin and ghrelin supplementation, in vitro, to normal
lungs increased RA receptor α/γ expression whereas administration of bombesin and ghrelin
antagonists to normal and hypoplastic lungs decreased it.
 These data reveal for the first time that there is a link between neuroendocrine factors and
RA, and that neuroendocrine factors sensitise the lung to the RA action through RA receptor
modulation.
Abstract Congenital diaphragmatic hernia (CDH) is characterised by a spectrum of lung hypo-
plasia and consequent pulmonary hypertension, leading to high morbidity and mortality rates.
Moreover, CDH has been associated with an increase in the levels of pulmonary neuroendocrine
factors, such as bombesin and ghrelin, and a decrease in the action of retinoic acid (RA). The
present study aimed to elucidate the interaction between neuroendocrine factors and RA. In vitro
analyseswereperformedonSprague–Dawley rat embryos.Normal lung explantswere treatedwith
bombesin, ghrelin, a bombesin antagonist, a ghrelin antagonist, dimethylsulfoxide (DMSO), RA
dissolved in DMSO, bombesin plus RA and ghrelin plus RA. Hypoplastic lung explants (nitrofen
model) were cultured with bombesin, ghrelin, bombesin antagonist or ghrelin antagonist. The
lung explants were analysed morphometrically, and retinoic acid receptor (RAR) α, β and γ
expression levels were assessed via Western blotting. Immunohistochemistry analysis of RAR was
performed in normal and hypoplastic lungs 17.5 days post-conception (dpc). Compared with the
controls, hypoplastic lungs exhibited significantly higher RARα/γ expression levels. Furthermore
considering hypoplastic lungs, bombesin and ghrelin antagonists decreased RARα/γ expression.
Normal lung explants (13.5 dpc) treated with RA, bombesin plus RA, ghrelin plus RA, bombesin
or ghrelin exhibited increased lung growth. Moreover, bombesin and ghrelin increased RARα/γ
expression levels, whereas the bombesin and ghrelin antagonists decreased RARα/γ expression.
This study demonstrates for the first time that neuroendocrine factors function as lung growth
regulators, sensitising the lung to the action of RA through up-regulation of RARα and RARγ.
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Introduction
Congenital diaphragmatic hernia (CDH) is a severe
developmental anomaly with a mean incidence of 1:3000
live births and a poorly understood aetiology (van den
Hout et al. 2009; Keller et al. 2010; Nogueira-Silva et al.
2011). This congenital anomaly is characterised by a
diaphragmatic defect that allows intra-thoracic herniation
of abdominal organs and maldevelopment of the alveoli
and pulmonary vessels (van Loenhout et al. 2009). Thus,
newborns with CDH develop pulmonary hypoplasia
and pulmonary hypertension and, consequently, severe
respiratory failure. In fact, among the known causes of
severe respiratory failure in newborns, CDH remains the
most life threatening (Goshe et al. 2005).
Despite the increased understanding of the
pathophysiology of CDH and recent advances in
neonatal care, CDH remains a challenging condition that
is associated with high morbidity and mortality rates
(Pereira-Terra et al. 2015a; Pereira-Terra et al. 2015b).
Thus, the development of a less invasive, safer and cheaper
approach with minimum risk to the mother and the fetus
is crucial (Leeuwen & Fitzgerald, 2014). To this end, a
search for less invasive antenatal approaches that promote
fetal lung growth has emerged.
Retinoic acid (RA), an active metabolite of vitamin
A, binds to specific RA receptors (RARs and RXRs)
and functions as an essential signal for lung growth
and differentiation (The´baud et al. 1999). Indeed, RA
is involved in various phenomena related to lung
morphogenesis, including the formation of the lung
primordium, distal bud outgrowth, differentiation of
epithelial cells and the distal mesenchyme, and promotion
of alveolisation by inducing the formation of secondary
septae. Additionally, the retinoid signalling pathway has
been shown to be involved in CDH pathophysiology.
For example, decreased plasma levels of retinol and
retinol-binding protein are observed in individuals with
CDH (Major et al. 1998). Furthermore, CDH has been
observed in patients with deletions within chromosome
15q, which contains the gene encoding cellular retinoic
acid binding protein (CRABP1) (Pober, 2007). In animal
studies, double RAR knockouts (RARα and RARβ
knockouts) were shown to exhibit unilateral lung agenesis
and contralateral lunghypoplasia (Mendelsohn et al. 1994;
Beurskens et al. 2009). Moreover, in a nitrofen-induced
CDH rat model, which is the best animal model
mimicking CDH, inhibition of the RA signalling pathway
was reported to occur, and rescue of nitrofen-induced
pulmonary hypertension in fetal rat lungs was observed
uponmaternal administration of RA (Antipatis et al. 1998;
Asabe et al. 1999; The´baud et al. 1999; Baptista et al. 2005;
Sugimoto et al. 2008; Doi et al. 2010; Ruttenstock et al.
2011).
The neuroendocrine factors bombesin and ghrelin are
produced by pulmonary neuroendocrine cells (PNECs)
and appear to play important roles in lung development
and maturation from intrauterine life to the postnatal
period (Asabe et al. 1999). Furthermore, CDH has been
associated with increased bombesin and ghrelin levels.
Moreover early maternal administration of ghrelin during
gestationwas shown to attenuate pulmonary hypoplasia in
a CDH animal model (Santos et al. 2006; Cutz et al. 2007).
Therefore, the aimof this studywas to evaluate theputative
association between neuroendocrine factors (bombesin
and ghrelin) and RA during normal and hypoplastic fetal
lung development.
Methods
Ethical approval
Animal experiments were performed according to
the Portuguese law for animal welfare (Dia´rio da
Repu´blica, Portaria 1005/92). Animals were housed in an
accredited animal facility and treated as specified by the
recommendations of the NIH guidelines and the Guide
for the Care and Use of Laboratory Animals, published by
the National Academy Press (NIH publication No 85-23,
revised 1996).
Animal model and experimental design
Female Sprague–Dawley rats (225 g; Charles River,
Barcelona, Spain) were maintained in appropriate cages
under controlled conditions and fedwith commercial solid
food. The rats were mated and checked daily for vaginal
plugs. The day of plugging was defined as gestational
day 0.5 for the purpose of time dating. According
to the nitrofen-induced CDH rat model, randomly
selected pregnant rats received 100 mg of nitrofen
(2,4-dichlorophenyl-p-nitrophenylether) dissolved in
1 ml of olive oil via gavage on 9.5 dpc (days post-
conception) (hypoplastic group) (Nogueira-Silva et al.
2011).Control animals only receivedonlyolive oil (control
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Table 1. Schematic representation of the study design
Explants
Normal
+Bombesin
+Bombesin
+Ghrelin
+Ghrelin
+Bombesin antagonist
+Bombesin antagonist
+Ghrielin antagonist
+Ghrielin antagonist
+Retinoic acide (RA)
+Bombesin+RA
+Ghreline+RA
Nitrofen
group). The dams were anaesthetised with a pentobarbital
overdose (150 mg kg−1 I.P.) followed by decapitation.
The fetuses then were removed through Caesarean section
and killed by decapitation. For lung explant cultures, the
fetuseswere harvested at 13.5 dpc and their lungs dissected
and incubated with different compounds or inhibitors
(Table 1). Lungs from 17.5 dpc fetuses were processed
for immunohistochemistry.
Immunohistochemistry
Immunostaining was performed in formalin-fixed and
paraffin-embedded control and hypoplastic lungs at
17.5 dpc, as previously described (Nogueira-Silva et al.
2012). All the slides were stained at the same time.
The RARα antibody (Santa Cruz Biotechnology Inc.,
Heidelberg, Germany) was used at a 1:200 dilution, the
RARβ antibody (Santa Cruz Biotechnology Inc.) at a 1:50
dilution, and the RARγ antibody (Abcam, Cambridge,
UK) at a 1:100 dilution. Incubation with UltraVision
detection system anti-polyvalent horseradish peroxidase
(Lab Vision Corporation, Fremont, CA, USA) was carried
out according to themanufacturer’s instructions.Negative
controls were performed by omitting the primary anti-
bodies. The slides were photographed with an Olympus
BX61 microscope (Olympus, Tokyo, Japan). At least three
independent experiments were performed.
Fetal lung explant culture
Control and hypoplastic lungs were removed from
13.5 dpc embryos, harvested and dissected in DPBS
(Lonza, Basel, Switzerland) under a dissectionmicroscope
(SZX16, Olympus). The lungs were then transferred to
nucleopore membranes (Isopore membrane filters, Milli-
pore, Darmstadt, Germany) and cultured for 4 days as
previously described (Piairo et al. 2011).
The control and hypoplastic lung cultures were
incubated daily with 1 μM bombesin (Tocris Bioscience,
Bristol, UK) (Kresch et al. 1999) or 30 nM ghrelin (Peptides
International, Louisville, KY, USA) (Nunes et al. 2008)
and with one of the following treatments: 10−6 M RA
(Sigma-Aldrich, St. Louis, MO, USA) dissolved in 0.1%
dimethylsulfoxide (DMSO), 0.1% DMSO alone, 1 μM
bombesin plus 10−6 M RA, 30 nM ghrelin plus 10−6 M RA,
10−7 M bombesin antagonist (Phoenix Pharmaceuticals,
Mannheim, Germany) (Hosli et al. 1993) or 10−6 M
ghrelin antagonist (Bachem AG, Bubendorf, Switzerland)
(Nunes et al. 2008). Thus, this set of experiments
included the following 14 groups: control (n = 27),
control plus ghrelin (n = 27), control plus bombesin
(n = 27), control plus ghrelin antagonist (n = 27),
control plus bombesin antagonist (n = 27), control plus
DMSO (n = 27), control plus RA dissolved in DMSO
(n = 27), control plus bombesin and RA (n = 27),
control plus ghrelin and RA (n = 27), nitrofen (n = 27),
nitrofen plus ghrelin (n = 27), nitrofen plus bombesin
(n = 27), nitrofen plus bombesin antagonist (n = 27)
and nitrofen plus ghrelin antagonist (n = 27). The
culture medium was replaced every 48 h. Lungs were
collected for Western blotting after 4 days in culture
(96 h).
Morphometric analysis. Branching morphogenesis was
monitored daily by photographing the explants using
a stereomicroscope equipped with a camera (DP71,
Olympus). At day 0 (D0: 0 h) and day 4 (D4: 96 h) of
culture, branching, the epithelial and total perimeters,
and the epithelial and total areas were measured using
ImageJ image processing and analysis software (version
1.44; ImageJ, US National Institutes of Health, Bethesda,
MD, USA).
For all experimental conditions, the results were
expressed as the D4/D0 ratio.
Western blotting
Lung explants were processed for Western blot analysis
using an RARα antibody at a 1:500 dilution, an RARβ
antibody at a 1:200 dilution and an RARγ antibody (Santa
Cruz Biotechnology Inc.) at a 1:500 dilution.
Protein lysates of pooled lung explants (n = 9) from
each group were obtained via homogenisation of the fetal
tissue with a pellet pestle motor (Kimble Kontes, Chicago,
IL, USA) as previously described (Nogueira-Silva et al.
2013). Different pooled lung samples were used, and three
independent experiments were performed. A quantity of
10μg of protein was loaded onto 8% acrylamideminigels,
and the procedure was performed as previously described
(Piairo et al. 2011). The blots were incubated with RARα,
RARβ or RARγ antibodies overnight at 4 °C, followed
by an appropriate secondary anti-rabbit (1:5000 dilution)
(Santa Cruz Biotechnology Inc.) or anti-mouse (1:2000
C© 2015 The Authors. The Journal of Physiology C© 2015 The Physiological Society
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dilution) (Cell Signaling Technology, Danvers, MA, USA)
horseradish peroxidase-conjugated antibody. The blots
were subsequently developed with the Super Signal West
Femto Substrate (Pierce Biotechnology, Waltham, MA,
USA), and the chemiluminescent signal was captured
using a Chemidoc XRS system (Bio-Rad, Philadelphia,
PA, USA). As a loading control, the blots were probed
with a β-tubulin antibody (1:150,000 dilution; Abcam).
Quantitative analysis was performed using Quantity One
analysis software (version 4.6.5 1D, Bio-Rad).
Statistical analysis
All quantitative data are presented as means ± SEM.
Statistical analysis was performed via one-way ANOVA
using SigmaStat 3.5 (Systat Software Inc., San Jose, CA,
USA). The Bonferroni test was applied for post-test
analysis. The threshold for statistical significance was set
at P < 0.05.
Results
RAR expression pattern in normal and hypoplastic
17.5 dpc rat lungs
Immunohistochemistry analyses revealed that RARα, β
and γ were expressed in the epithelial and mesenchymal
cells of both control and hypoplastic lungs (Fig. 1).
Moreover, RARα and RARγ expression appeared to
be higher in hypoplastic lungs than in control lungs
(Fig. 1).
Bombesin, ghrelin, RA, bombesin plus RA and ghrelin
plus RA supplementation analyses
To evaluate the effects of neuroendocrine factors
(bombesin and ghrelin), RA, and bombesin or ghrelin
plus RAon lung growth, control and hypoplastic fetal lung
explants were performed. Figure 2A shows representative
examples of control fetal lung explants treated with
bombesin (1 μM), ghrelin (30 nM), RA (10−6 M),
bombesin plus RA or ghrelin plus RA. In normal lungs,
bombesin, ghrelin, RA and the combination of bombesin
or ghrelin with RA appear to stimulate lung growth
(Fig. 2A). In fact, all of these compounds increased the
total number of peripheral airway buds, and bombesin,
RA, bombesin plus RA and ghrelin plus RA also increased
the epithelial perimeter (Fig. 2B). Moreover RA increases
the total area of the lungs (Fig. 2B).
In contrast, bombesin and ghrelin did not interfere
with hypoplastic lung growth, as shown in Fig. 2C and
confirmed through morphometric analysis (Fig. 2D).
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Figure 1. Retinoic acid receptor (RAR) expression patterns in
17.5 days post-conception rat lungs under normal and
hypoplastic conditions
A, RARα. B, RARβ. C, RARγ . D, negative immunohistochemistry
control: omission of the primary antibodies.
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RAR protein expression after bombesin, ghrelin,
bombesin plus RA, and ghrelin plus RA
supplementation
To investigate the possible mechanisms underlying the
effects of bombesin, ghrelin and neuroendocrine factors
plus RA interactions, the protein levels of RARα, β
and γ were assessed. RARα and RARγ expression levels
were higher in untreated hypoplastic lungs than in
control lungs (Fig. 3A and C). Bombesin and ghrelin
supplementation induced RARα and RARγ expression in
normal lungs (Fig. 3A and C). Bombesin plus RA and
ghrelin plus RA also induced RARα expression (Fig. 3A).
In contrast, ghrelin-treated hypoplastic lungs exhibited
decreased RARα and RARγ expression (Fig. 3A and C).
The expression of RARβ was similar in all of the studied
groups (Fig. 3B).
Effect of RA on RAR expression in normal fetal lungs
To assess the effect of RA on RARα, β and γ, the levels of
these three proteins were evaluated. In control lungs, RA
led to decreasedRARα andRARγ expression but increased
RARβ expression (Fig. 4).
D0
D4
D0
D4
25
20
15
10
N
um
be
r 
of
 p
er
ip
he
ra
l
ai
rw
ay
 b
ud
s 
(D
4/
D
0)
N
um
be
r 
of
 p
er
ip
he
ra
l
ai
rw
ay
 b
ud
s 
(D
4/
D
0)
E
pi
th
el
ia
l P
er
im
et
er
(D
4/
D
0)
5
0
14
12
10
6
8
E
pi
th
el
ia
l P
er
im
et
er
 (
D
4/
D
0)
4
0
2
16
12
8
4
0
12
10
6
8
2
4
0 T
ot
al
 A
re
a 
(D
4/
D
0)
4
3
2
1
0
5
4
3
2
To
ta
l A
re
a 
(D
4/
D
0)
1
0
CTRBomb
Bomb GrlN Bomb GrlN Bomb GrlN
Grl DMSO RA Bomb
+RA
Grl
+RA
CTRBomb Grl DMSO RA Bomb
+RA
Grl
+RA
CTR Bomb Grl DMSO RA Bomb
+RA
Grl
+RA
CTR DMSO Bomb(1μm) Grl(30nm) Bomb+RA
BombHypoplastic (N)
Grl+RA
Grl
RA(10–6M)
A
B
C
D
Figure 2. Branching morphogenesis of rat lung explant cultures treated with bombesin (Bomb), ghrelin
(Grl), retinoic acid (RA), bombesin plus RA (Bomb + RA) or ghrelin plus RA (Grl + RA)
A, the upper panel is representative of normal lung explants (CTR) at day 0 (D0); the bottom panel represents
untreated lung explants (CTR) and explants treated with DMSO, Bomb, Grl, RA, Bomb plus RA or Grl plus RA
on day 4 (D4). B, morphometric analysis of the number of peripheral airway buds, epithelial perimeter and total
area. C, the upper panel is representative of the hypoplastic lung explants (N) at D0; the bottom panel represents
untreated hypoplastic lung explants (N) and hypoplastic explants treated with Bomb or Grl on D4. D, morphometric
analysis of the number of peripheral airway buds, epithelial perimeter and total area. The results are expressed as
the D4/D0 ratio. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.
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Effects of bombesin and ghrelin antagonists
on normal and hypoplastic lung growth and RAR
expression
To confirm the roles of bombesin and ghrelin in normal
and hypoplastic lung development, antagonists of these
peptides were added to lung explants. The bombesin and
ghrelin antagonists significantly inhibited lung growth,
as indicated by decreases in the total number of peri-
pheral airway buds and the epithelial perimeter (Figs 5
and 7A). However, the total area remained unchanged
after treatment with the antagonists (data not shown).
Regarding RAR protein expression, explants treated
with the bombesin and ghrelin antagonists exhibited a
statistically significant decrease in RARα expression (Figs
6A and 7B). In contrast, RARβ expression in treated
explants was similar to that in untreated explants, and
a slight decrease in RARγ expression was observed in
explants treated with these antagonists (Figs 6B and C,
and 7B and C).
Discussion
Congenital diaphragmatic hernia (CDH) is associated
withpulmonaryhypoplasia, and it has been shown thatRA
signalling is involved in the establishment of this disease.
Furthermore, CDH has been linked to an increased levels
of neuroendocrine factors. This report describes a putative
link between neuroendocrine factors and the RA pathway
in normal and hypoplastic lung development for the first
time.
Retinoids such as vitamin A and its derivatives are
crucial for growth, development and tissue differentiation
(Blomhoff & Blomhoff, 2006). RA acts by binding to
nuclear receptors that exist in three different isoforms:
α, β and γ (Mactier & Weaver, 2005). RA receptors are
expressed from the earliest stages of embryonic lung
development into postnatal life. RARα is ubiquitously
expressed at consistent levels over time during lung
development, whereas RARβ is excluded from the distal
epithelium during branching but is still present in
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the epithelial cells of proximal and mid-sized airways
(Wongtrakool et al. 2003; Roth-Kleiner & Post, 2005).
In this study, we show that in the canalicular stage, RARs
are expressed in epithelial and mesenchymal cells in both
normal and hypoplastic lungs; moreover, the levels of
RARα and RARγ appear to be increased in hypoplastic
lungs, in contrast to what Rajatapiti et al. (2006) have
shown previously in qualitative analysis (Fig. 1).
Classically, RA is described as one of the major
stimulators of lung development. In CDH, several growth
factors, including RA, have been observed to promote
lung branching when exogenously administered (Baptista
et al. 2005; Keller et al. 2010). Furthermore, the RA
signalling pathway has been shown to be involved
in CDH pathogenesis and pulmonary hypoplasia. For
instance, the incidence rate of CDH is higher in litters
born to dams fed vitamin A-deficient diets (Andersen
et al. 1941). RARα/RARβ double knockout mice display
diaphragmatic hernia (Chen et al. 2003); however, when
mutations affect only one isoform of one receptor, no fetal
anomalies are detected, suggesting functional redundancy
between various receptors and isoforms (Azais-Braesco
& Pascal, 2000). Nitrofen suppresses the RA response
element (Major et al. 1998), and in vitro assays have
shown that nitrofen inhibits Retinaldehyde dehydrogenase
2 (RALDH2) (Mendelsohn et al. 1994). In humans,
infants with CDH exhibit lower plasma retinol levels than
healthy infants (Mey et al. 2003; Beurskens et al. 2007).
Additionally, it has been demonstrated that antenatal
administration of vitaminA reduces the incidence ofCDH
and restores lungmaturation in the nitrofen ratmodel and
that RA improves lung branching in CDH lungs in fetal
lung explant cultures (The´baud et al. 1999, 2001; Babiuk
et al. 2004).
Focusing on neuroendocrine cells, studies conducted
during the last decade have revealed a complex functional
role for pulmonary neuroendocrine cells (PNECs). In the
early stages of lungdevelopment, PNECs act asmodulators
of fetal lung growth and differentiation, whereas at the
time of birth, they act mainly as airway O2 sensors
Figure 5. Branching morphogenesis in rat lung explant cultures (Control) treated with a bombesin or
ghrelin antagonist (Bomb Ant or Grl Ant)
The number of peripheral airway buds and the epithelial perimeter. The results are expressed as the D4/D0 ratio.
∗∗∗P < 0.001.
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involved in neonatal adaptation (Andersen et al. 1941).
The major neuroendocrine peptides in the lung are
bombesin andghrelin.Recentdata fromourgroup showed
that ghrelin is overexpressed in human hypoplastic lungs
and the lungs of CDH model rats compared with normal
lungs (Santos et al. 2006). Bombesin expression has been
shown to be higher in CDH lungs than in normal lungs
(Santos et al. 2006; Cutz et al. 2007). These increases
in some growth factors observed in CDH lungs might
represent a compensatory response of hypoplastic lungs
attempting to recover normal levels of lung growth (Santos
et al. 2006).
Given that PNECs behave as lung sensors and that RA is
a classical lung growth factor, and the levels of both neuro-
endocrine peptides and RA are affected in hypoplastic
lungs, we hypothesised a putative link between these two
important lung regulators.
In thepresent study, itwasdemonstrated thatbombesin,
ghrelin and particularly RA, or bombesin or ghrelin
combined with RA, promote normal lung branching
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were normalised to β-tubulin, which was used as a loading control. The data are presented as means ± SEM.
∗P < 0.05; ∗∗P < 0.01.
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and increase the lung epithelial perimeter (Fig. 2A and
B). Moreover, exogenous supplementation of bombesin
or ghrelin in normal lungs increased RARα and RARγ
expression but did not affect RARβ expression (Fig. 3). In
contrast, inhibition of bombesin or ghrelin decreased lung
branching as well as RARα and RARγ expression (Figs 5
and 6, respectively). Thus, these results demonstrate, for
the first time, that there is a link between neuroendocrine
factors and the RA signalling pathway. Moreover, RARα
and RARγ appear to be the major mediators between
these two apparently different pathways. Indeed, these
results suggest that the action of neuroendocrine factors
during lung growth is at least mediated by an increase
in RARα and RARγ expression, indicating that RA
pulmonary sensitisation is mediated by neuroendocrine
factors through RARα and RARγ.
Furthermore, the results showed that RA
supplementation in normal lungs decreased RARα
and RARγ expression and increased RARβ expression
(Fig. 4). A possible explanation for this observation
is that neuroendocrine cells sense the increase in lung
growth mediated by RA and consequently decrease the
production of neuroendocrine factors, which in turn
leads to decreased RARα and RARγ expression. However,
the possibility of a direct down-regulation effect of RA
on RAR expression cannot be excluded. RARβ expression
was stimulated by RA supplementation and remained
unchanged by bombesin and ghrelin modulation. These
results exclude the involvement of RARβ in the RA/PNEC
interaction with respect to lung growth mechanisms.
Regarding pulmonary hypoplasia, according to the
literature, RARα and RARγ are overexpressed in hypo-
plastic lungs compared with normal lungs. In vitro
bombesin and ghrelin supplementation in hypoplastic
lung explant cultures did not affect the examined lung
morphometric parameters (Fig. 2B and D), probably
because these receptors are already overexpressed. The
expression of RARα and RARγ slightly decreases in
hypoplastic lungs after ghrelin supplementation (Fig. 3).
We do not have a plausible explanation for this result.
However, this finding reinforces the idea that there is
an association between neuroendocrine factors and RA
NORMAL
• Bomb
• Grl
• RAR
Effect on RAR expression Effect on RAR expression
Bomb
Bomb
RARα RARα
CDH
Grl
Grl
Bomb Ant
Grl Ant
Bomb
Grl
Bomb Ant
Grl Ant
RAR
Figure 8. Schematic representation of the putative link between neuroendocrine cells and the retinoic
acid signalling pathway
In the upper panel, on the left side of the scheme we have represented the normal fetal lung expressing neuro-
endocrine products: bombesin (Bomb) and ghrelin (Grl) as well as retinoic acid receptors (RAR). On the right side
of the scheme we have represented the CDH fetal lungs, which express increased (↑) levels of neuroendocrine
products (Bomb and Grl) as well as RAR. On the bottom panel, we represent the RAR explants expression after
modulation (agonists and antagonists) of neuroendocrine products. Focusing on isoform α, in control explants,
RAR(α) expression is significantly increased (↑) and decreased (↓) with addition of agonists (full arrows, Bomb and
Grl) and antagonists (dashed arrows, Bomb Ant and Grl Ant) of neuroendocrine products, respectively. Regarding
CDH explants, addition of neuroendocrine products does not induce and additionally increment RAR(α) expression
when compared with untreated CDH explants (=), but addition of neuroendocrine antagonists (Bomb Ant and Grl
Ant) induces a significant decrease (↓) of RAR(α) expression. As a result of these findings, we propose a mechanism
of interaction between bombesin and ghrelin with the retinoic acid signalling pathway through the modulation of
RAR expression that seems to be working in the hypoplastic lungs.
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signalling. Moreover, inhibition of bombesin or ghrelin
significantly decreased RARα expression as well as lung
branching (Fig. 7), reinforcing our hypothesis.
It has largely been demonstrated that RA significantly
increases lung branching in hypoplastic lungs after RA
supplementation in vitro. Moreover, hypoplastic lungs
overexpress bombesin and ghrelin (Cutz et al. 2007). In
this study, we observed an increase in RARα and RARγ
expression in hypoplastic lungs that might be explained
by the compensatory overexpression of bombesin and
ghrelin in these lungs (Fig. 3). This is in agreement with
the effect of neuroendocrine factor supplementation in
normal lungs. In Fig. 8, a putative mechanism for the
link between neuroendocrine cells and the RA pathway is
presented.
In summary, based on these results, we can conclude
that neuroendocrine factors act as regulators of lung
growth, sensitising the lungs to the action of RA through
RARα and RARγ up-regulation.
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